Colorectal cancer screening in average risk individuals.
Colorectal cancer is the third leading type of cancer, and the second leading cause of cancer-related death in the United States. Prevention of colorectal cancer should be achievable by screening programs that detect adenomas in asymptomatic patients and lead to their removal. In this manuscript, we review the major screening modalities, the advantages and disadvantages of each approach, the data supporting their use, and various issues affecting the implementation of each test. Screening guidelines will be reviewed, and future techniques for colorectal cancer screening examined.
Huang
Christopher S
CS
Section of Gastroenterology, Boston Medical Center, Boston, MA 02118, USA.
Lal
Subodh K
SK
Farraye
Francis A
FA
D000236:Adenoma / Q000517:prevention & control; D003110:Colonic Neoplasms / Q000517:prevention & control*; D023881:Colonography, Computed Tomographic; D003113:Colonoscopy; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009780:Occult Blood; D012004:Rectal Neoplasms / Q000517:prevention & control*; D012307:Risk Factors; D012812:Sigmoidoscopy